CRP and hepatocellular carcinoma: Therefore, molecular classification of HCC and assessment of serum/plasma selenium levels, hepatic GPx4 levels, CRP/IL-8 and radical stress markers [36] should help to identify target populations for therapeutic GPx4 modulation.